WLLW.TO
Price:
$0.09
Market Cap:
$12.98M
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-02-11
Stock Exchange
TSX
Ticker
WLLW.TO
According to Willow Biosciences Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.50. This represents a change of 3.37% compared to the average of -1.45 of the last 4 quarters.
The mean historical PE Ratio of Willow Biosciences Inc. over the last ten years is -2.07. The current -1.50 PE Ratio has changed 7.16% with respect to the historical average. Over the past ten years (40 quarters), WLLW.TO's PE Ratio was at its highest in in the March 2022 quarter at 13.01. The PE Ratio was at its lowest in in the June 2015 quarter at -1197.65.
Average
-2.07
Median
-1.11
Minimum
-8.76
Maximum
-0.43
Discovering the peaks and valleys of Willow Biosciences Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 210.18%
Maximum Annual PE Ratio = -0.43
Minimum Annual Increase = -89.04%
Minimum Annual PE Ratio = -8.76
Year | PE Ratio | Change |
---|---|---|
2023 | -0.95 | -0.66% |
2022 | -0.96 | -89.04% |
2021 | -8.76 | 210.18% |
2020 | -2.82 | 172.73% |
2019 | -1.04 | -30.99% |
2018 | -1.50 | 54.52% |
2018 | -0.97 | 124.14% |
2017 | -0.43 | -78.94% |
2016 | -2.06 | 73.20% |
2015 | -1.19 | 84.97% |
The current PE Ratio of Willow Biosciences Inc. (WLLW.TO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.56
5-year avg
-2.91
10-year avg
-2.07
Willow Biosciences Inc.’s PE Ratio is greater than MediPharm Labs Corp. (-2.10), less than Delta 9 Cannabis Inc. (-0.06), greater than Cardiol Therapeutics Inc. (-6.23), less than Aleafia Health Inc. (-0.17), less than StageZero Life Sciences Ltd. (-0.93),
Company | PE Ratio | Market cap |
---|---|---|
-2.10 | $28.77M | |
-0.06 | $1.51M | |
-6.23 | $185.89M | |
-0.17 | $8.07M | |
-0.93 | $4.08M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Willow Biosciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Willow Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Willow Biosciences Inc.'s PE Ratio?
How is the PE Ratio calculated for Willow Biosciences Inc. (WLLW.TO)?
What is the highest PE Ratio for Willow Biosciences Inc. (WLLW.TO)?
What is the 3-year average PE Ratio for Willow Biosciences Inc. (WLLW.TO)?
What is the 5-year average PE Ratio for Willow Biosciences Inc. (WLLW.TO)?
How does the current PE Ratio for Willow Biosciences Inc. (WLLW.TO) compare to its historical average?